Page last updated: 2024-09-03

gefitinib and Meningioma

gefitinib has been researched along with Meningioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamberlain, MC; Le Rhun, E; Taillibert, S1
Abrey, LE; Aldape, K; Chang, SM; Cloughesy, TF; Dancey, J; Deangelis, LM; Fine, HA; Gilbert, MR; Lamborn, KR; Lassman, AB; Lieberman, F; Mehta, M; Norden, AD; Prados, MD; Raizer, JJ; Robins, HI; Wen, PY; Yung, WK1

Trials

1 trial(s) available for gefitinib and Meningioma

ArticleYear
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
    Journal of neuro-oncology, 2010, Volume: 96, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Survival Analysis; Tomography, X-Ray Computed

2010

Other Studies

1 other study(ies) available for gefitinib and Meningioma

ArticleYear
Systemic therapy for recurrent meningioma.
    Expert review of neurotherapeutics, 2016, Volume: 16, Issue:8

    Topics: Gefitinib; Humans; Kruppel-Like Factor 4; Meningeal Neoplasms; Meningioma; Prospective Studies; Quinazolines; Vascular Endothelial Growth Factor A

2016